NEW YORK (GenomeWeb News) – ChromoTek today announced it has signed a contract with Bulldog Bio to distribute ChromoTek's entire line of affinity reagents in the US and Canada.

Portsmouth, NH-based Bulldog will sell and support ChromoTek's line of novel tools for protein and cell biology. Financial and other terms were not disclosed.

ChromoTek is based in Planegg-Martinsried, Germany and offers immunologic research tools derived from single domain alpaca antibodies for cell biology and proteomics. The company is a spinout of the Ludwig-Maximilians University Munich.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.